ArticleAnnals of surgical oncology2026
Single-Port Robotic Cytoreductive Surgery for Colon Cancer Peritoneal Recurrence with the da Vinci SP.
Article in Annals of surgical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
backgroundRobotic surgical platforms have demonstrated functional advantages in complex abdominal surgeries.
methodsA 61-year-old female patient with colon cancer exhibited ovarian and multiple peritoneal metastases 14 months after undergoing laparoscopic right hemicolectomy for colon cancer. The patient was referred to our institution for further management after bilateral salpingo-oophorectomy. After seven cycles of neoadjuvant chemotherapy, CRS was planned, including hysterectomy, rectal resection, left lower abdominal wall mass excision, greater omentectomy, cholecystectomy (gallbladder polyps), and hyperthermic intraperitoneal chemotherapy. The procedures were deemed feasible using the da Vinci SP system, and informed consent was obtained from the patient. A single port was introduced through a 4.5-cm umbilical incision. The peritoneal carcinomatosis index score was 7, and all procedures were completed, achieving complete cytoreduction (CC-0).
resultsThe entire procedure lasted 501 min, with an estimated blood loss of 150 mL. The patient had a maximum pain numerical rating score of 3 and was discharged without complications on day 9. Adjuvant chemotherapy was administered, and the patient has remained recurrence-free for ≥ 6 months at the time of reporting.
conclusionsSingle-port robotic CRS using the da Vinci SP appears feasible for highly selected cases with limited peritoneal metastases. This approach facilitates multi-quadrant dissection through a single incision, minimizes abdominal wall trauma, and potentially enhances postoperative recovery.
Indexed as
Identifiers
42319590What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.